CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation declared the most recent subsidizing grant under its US$ 200 million program to propel the improvement of antibodies that give wide assurance against SARS-CoV-2 variations and other betacoronaviruses.
Biotechnology | 09/04/2022 | By Sudeep Soparkar | 412
Collaboration between ICMR and Pharma companies to develop Dengue vaccine
With the rise in dengue cases across the country, the Indian Council of Medical Research (ICMR) has embarked on an initiative aiming to facilitate development of dengue vaccine. Vaccine manufacturer and pharma companies who have developed or have license of tetravalent dengue vaccine candidate and have successfully completed its phase I and phase II
Biotechnology | 07/03/2022 | By Darshana | 631
The US Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has formally granted Orphan Drug Designation (ODD) to Innovent Biologics's fully-human B-Cell Maturation Antigen (BCMA)-targetted Chimeric Antigen Receptor (CAR) T-cell therapy
Biotechnology | 17/02/2022 | By Darshana | 812
Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA Poland, announced it will focus on the development of bacteriophages as a sustainable alternative to antibiotics in the poultry industry
Biotechnology | 18/10/2021 | By Darshana | 742
An integrated clinical decision support system (CDSS) using artificial intelligence (AI) could be useful to health workers in primary and secondary healthcare settings to overcome the present challenges including a lack of adequate manpower in the system, according to a study sponsored by NITI Aayog and UK-Department of International Trade
Biotechnology | 01/09/2021 | By Darshana | 465
Nucleome unveils South Asia's largest genomics research centre in Hyderabad
In a move that will mark the beginning of a new era in India's genomics capability, Nucleome Informatics has unveiled South Asia's largest and most advanced genomics facility, NKC Centre for Genomics Research in Hyderabad
Biotechnology | 27/08/2021 | By Darshana | 453
MaxCyte, Inc., a leading provider of cell-engineering platform technologies, announced the signing of a clinical and commercial license with Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines.
Biotechnology | 10/08/2021 | By Darshana | 440
Pharmexcil seeks list of products requiring SION norms fixation from exporters
The Pharmaceutical Export Promotion Council of India (Pharmexcil) has asked exporters to provide a list of products requiring Standard Input Output Norms (SION) fixation to help them fulfill export obligations in a timely manner
Biotechnology | 02/08/2021 | By Darshana | 460
Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint clinical development and commercialization of HQP1351(olverembatinib), a third-generation BCR-ABL inhibitor and a core drug candidate of Ascentage Pharma
Biotechnology | 16/07/2021 | By Darshana | 634
Abbott gets CDSCO approval for marketing of estradiol, dydrogesterone FDC
Abbott, the global healthcare company, has received approval from the Subject Expert Committee (SEC) at Central Drugs Standard Control Organisation (CDSCO) for importing and marketing of the fixed dose combination of dydrogesterone+estradiol (2.5 mg + 0.5mg) tablets
Biotechnology | 15/07/2021 | By Darshana | 647
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy